Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$46.82 - $76.2 $163,542 - $266,166
3,493 Added 15.97%
25,368 $1.23 Million
Q3 2022

Nov 14, 2022

BUY
$70.55 - $111.58 $1.54 Million - $2.44 Million
21,875 New
21,875 $1.54 Million
Q2 2022

Aug 15, 2022

SELL
$50.24 - $80.48 $929,640 - $1.49 Million
-18,504 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$57.98 - $93.5 $460,303 - $742,296
-7,939 Reduced 30.02%
18,504 $1.48 Million
Q4 2021

Feb 14, 2022

BUY
$88.02 - $127.79 $354,016 - $513,971
4,022 Added 17.94%
26,443 $2.41 Million
Q3 2021

Nov 15, 2021

BUY
$122.75 - $162.68 $2.49 Million - $3.3 Million
20,300 Added 957.1%
22,421 $2.88 Million
Q2 2021

Aug 16, 2021

BUY
$105.76 - $154.96 $224,316 - $328,670
2,121 New
2,121 $323,000
Q3 2020

Nov 16, 2020

SELL
$45.65 - $61.81 $169,954 - $230,118
-3,723 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$29.15 - $61.54 $569,503 - $1.2 Million
-19,537 Reduced 83.99%
3,723 $229,000
Q1 2020

May 15, 2020

BUY
$25.01 - $42.4 $394,382 - $668,605
15,769 Added 210.51%
23,260 $750,000
Q4 2019

Feb 14, 2020

BUY
$24.55 - $38.13 $183,904 - $285,631
7,491 New
7,491 $263,000
Q3 2019

Nov 14, 2019

SELL
$25.78 - $34.8 $297,707 - $401,870
-11,548 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$23.08 - $37.01 $197,564 - $316,805
-8,560 Reduced 42.57%
11,548 $339,000
Q1 2019

May 15, 2019

SELL
$27.81 - $40.78 $323,903 - $474,964
-11,647 Reduced 36.68%
20,108 $687,000
Q4 2018

Feb 14, 2019

BUY
$28.91 - $50.0 $218,790 - $378,400
7,568 Added 31.29%
31,755 $1.01 Million
Q3 2018

Nov 14, 2018

BUY
$30.85 - $50.65 $435,386 - $714,823
14,113 Added 140.09%
24,187 $1.16 Million
Q2 2018

Aug 14, 2018

BUY
$13.95 - $32.65 $140,532 - $328,916
10,074 New
10,074 $312,000

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.11B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.